- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05672004
Implementation of ProMuscle in Daily Practice (PUMP-fit)
Implementation of the Combined Lifestyle Intervention ProMuscle for Community-living Older Adults in Community-care Practices.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
ProMuscle is a combined lifestyle intervention that has been shown effective in improving muscle mass, muscle strength, and physical functioning in community-dwelling older adults. Potentially, it could facilitate older people in maintaining their functional independence.
Despite the promising results, ProMuscle is still not part of daily care. Previously factors influencing successful implementation were identified and implementation strategies targeting these factors were developed and formatted as an implementation toolbox for healthcare professionals.
To increase the likelihood of successful implementation of ProMuscle, this study aims to investigate the PUMP-fit strategy (implementation toolbox) effectiveness on the adoption of ProMuscle in community-care
A hybrid type 3 stepped wedge cluster trial with a mixed method analysis will be conducted to assess the effectiveness of the PUMP-fit implementation toolbox. A stepped wedge trail is chosen because of the ability to compare between clusters, but also within clusters.
Moreover, ProMuscle is already found effective, and the researchers hypothesized that the implementation toolbox should be assessable for all healthcare professionals in the 'Foodvalley'. At last, a stepped wedge design is recommended if there is limited time and a small sample of professionals to recruit from in comparison to the total sample size that is needed to detect any effect.
In addition, the researchers hypothesized that the program would be adapted to specific contexts' outcomes from the recipients of ProMuscle will be collected. A hybrid type three trial aims to investigate the implementation as a primary outcome and the effect of the (adapted) intervention as a secondary outcome.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Utrecht, Netherlands, 3508 GA
- University Medical Center Utrecht
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
To be eligible to participate in this study, healthcare professionals must met the following criteria:
- Physical therapist, lifestyle coach or dietician in one of the communities in the Foodvalley in the Netherlands
- Interested in combined lifestyle programs for older adults
- Frequently involved in maintaining physical functioning in older adults
In and exclusion criteria for older residents receiving ProMuscle are:
Inclusion criteria:
- Aged 65 years or older
- Living in one of the eight communities of the 'Foodvalley' (Ede, Wageningen, Nijkerk, Rhenen, Veenendaal, Barneveld, Scherpenzeel, Renswoude)
- Able to understand Dutch
- Are pre-frail or frail (score 1 or more points on the Fried frailty criteria), or report loss of muscle strength
Exclusion criteria:
- One or more red flags for participating in progressive resistance exercise without consent of a medical specialist or general practitioner
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Implementation as usual
Healthcare professionals will be instructed to implement ProMuscle in their practice as usual
|
First, healthcare professionals will receive the ProMuscle training from one of the researchers during a one-hour online meeting. At the end of the training healthcare professionals are informed about the mandatory conditions to implement ProMuscle (champion, material, approval of management). Healthcare professionals receive a questionnaire about their readiness for implementation. The results of this questionnaire are directly visible. Results contain a graph of possible barriers for implementation in their practice. Hereafter they will be instructed to start with implementation as usual. |
|
Experimental: PUMP-fit strategy: Implementation toolbox
Healthcare professionals receive a personal implementation toolbox, tailored to their contexts' barriers for implementation
|
Healthcare professionals will receive the ProMuscle training from one of the researchers during a one-hour online meeting (during the control period). Healthcare professionals will be informed about the platform and toolbox. Healthcare professionals receive a personal log-in for the online platform. Healthcare professionals receive a questionnaire about their readiness for implementation. The results of this questionnaire are directly visible on the platform Within the separate environment of the online platform, healthcare professionals can access their implementation toolbox. The toolbox is tailored to their personal context based on the results of the 'Readinesstool'. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adoption of ProMuscle
Time Frame: 36 weeks
|
The number of healthcare professionals delivering ProMuscle is measured with administrative data and the REport of Sustainment Scale (PRESS).
Because it is not possible to measure adoption at baseline, The Measure of Innovation-Specific Implementation Intentions (MISII) questionnaire will be used to measure adoptability (the attention to adopt an EBP) at T0
|
36 weeks
|
|
Fidelity of ProMuscle
Time Frame: 36 weeks
|
Fidelity is the degree to which an intervention was implemented as prescribed.
The number of activities described in the ProMuscle guideline executed by the healthcare professionals will be assessed with a self-report checklist based on the content of the ProMuscle intervention.
Comparing the outcomes of fidelity before and after receiving the PUMP-fit strategy can indicate whether the toolbox contributed to the fidelity of delivery of ProMuscle.
|
36 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fidelity of the PUMP-fit strategy
Time Frame: 24 weeks
|
Fidelity is the degree to which an intervention was implemented as prescribed. For the PUMP-fit strategy, fidelity is defined as the degree to which the activities described in the online implementation toolbox are implemented as prescribed. The number of implementation activities described in the implementation toolbox and the time healthcare professionals are active in the implementation toolbox will be collected from the online platform (tracking activity). Fidelity according to healthcare professionals will be assessed with a self-report containing statements based on the Fidelity of Implementation (FOI) framework. The statements are scored with a 5-point Likert scale, the higher the score, the higher the fidelity. In addition, the experience of healthcare professionals about the fidelity will be investigated during the process evaluation guided by the domain "implementation" of the RE-AIM framework. |
24 weeks
|
|
Acceptability of the PUMP-fit strategy
Time Frame: 36 weeks
|
Acceptability will be measured with the translated Acceptability of Intervention Measure (AIM).
The AIM contains four statements about the acceptability of the PUMP-fit implementation strategy.
Statements are scored on a five-point Likert scale.
The higher the score the higher the acceptability of the PUMP-fit strategy.
|
36 weeks
|
|
Appropriateness of the PUMP-fit strategy
Time Frame: 36 weeks
|
Appropriateness will be measured with the translated Intervention Appropriateness Measure (IAM).
The IAM contains four statements about the appropriateness of the PUMP-fit implementation strategy.
Statements are scored on a five-point Likert scale.
The higher the score the higher the appropriateness of the PUMP-fit strategy.
|
36 weeks
|
|
Feasibility of the PUMP-fit strategy
Time Frame: 36 weeks
|
Feasibility will be measured with the translated Feasibility of Intervention Measure (FIM) questionnaire.
The FIM contains four statements about the feasibility of the PUMP-fit implementation strategy.
Statements are scored on a five-point Likert scale.
The higher the score the higher the feasibility of the PUMP-fit strategy.
|
36 weeks
|
|
Barriers and facilitators for implementation of ProMuscle
Time Frame: 36 weeks
|
Barriers and facilitators will be assessed with a questionnaire developed by the research group. The questionnaire contains statements about different factors that could influence implementation (CFIR framework) and is based on the 'Wandersman readiness thinking tool' and 'Organization Readiness'. Statements are rated on a 5-point Likert scale. Factors that are scored three or lower will be defined as barriers. Factors that are scored with four of higher will be defined as facilitators. Moreover, during the washout period and process evaluation barriers and facilitators will be identified in interviews with healthcare professionals implementing ProMuscle. |
36 weeks
|
|
Acceptability of ProMuscle
Time Frame: 36 weeks
|
Acceptability of ProMuscle will be measured with the translated Acceptability of Intervention Measure (AIM) by the start of the implementation of ProMuscle (T0).
Four statements are scored on a five-point Likert scale.
The higher the score, the higher the score the higher the acceptability of the ProMuscle intervention
|
36 weeks
|
|
Appropriateness of ProMuscle
Time Frame: 36 weeks
|
Appropriateness will be measured with the translated Intervention Appropriateness Measure (IAM) by the start of the implementation of ProMuscle (T0).
Four statements are scored on a five-point Likert scale, the higher the score the higher the appropriateness of ProMuscle.
|
36 weeks
|
|
Feasibility of ProMuscle
Time Frame: 36 weeks
|
Feasibility will be measured with the translated Feasibility of Intervention Measure (FIM) questionnaire by the start of the implementation of ProMuscle (T0).
Four statements are scored on a five-point Likert scale, the higher the score, the higher the score the higher the feasibility of the ProMuscle intervention
|
36 weeks
|
|
Reach of ProMuscle
Time Frame: 36 weeks
|
Reach is defined as the number of older adults and will be measured by administrative data.
|
36 weeks
|
|
Sustainment of ProMuscle
Time Frame: 54 weeks
|
Sustainment of the implementation of ProMuscle will be measured with the Program Sustainability Assessment Tool (PSAT) and during a one-hour focus group guided by the RE-AIM framework (domain Maintenance) to assess if ProMuscle became part of daily care.
|
54 weeks
|
|
Physical functioning recipients of ProMuscle
Time Frame: 54 weeks
|
The Short Physical Performance Battery (SPPB) is conducted by participating healthcare professionals to asses physical functioning.
|
54 weeks
|
|
Functional lower extremity strength recipients of ProMuscle
Time Frame: 54 weeks
|
Repeated chair-rise test is conducted by participating healthcare professionals to assess functional strength.
|
54 weeks
|
|
Leg strength recipients of ProMuscle
Time Frame: 54 weeks
|
The one repetition (1RM) of leg strength is performed on leg press machines. The 1RM is conducted by participating healthcare professionals. The 1RM measures the maximal strength and can be used to develop the exercise program. |
54 weeks
|
|
Functional mobility recipients of ProMuscle 1RM
Time Frame: 54 weeks
|
Functional mobility is measured with the Timed-Up-And-Go test (TUG).
|
54 weeks
|
|
Care dependency recipients of ProMuscle
Time Frame: 54 weeks
|
Healthcare professionals report the current health status of the recipients in terms of care dependency.
Recipients are asked if they receive care.
Answers can be categorized as no care, care from spouse or family, domestic worker, home care, nursing or other help.
|
54 weeks
|
|
Lean body mass recipients ProMuscle
Time Frame: 54 weeks
|
Lean body mass is measured with the bioelectrical impedance analysis (BIA)
|
54 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lisette Schoonhoven, prof, Julius Center, University Medical Center Utrecht, The Netherlands
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22/050
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frailty
-
University of PennsylvaniaCompleted
-
McMaster UniversityRecruitingFrailty | Frailty Syndrome | Frail Older Adults | Frailty in AgingCanada
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
Universidad Francisco de VitoriaActive, not recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric HealthSpain
-
University of IcelandLandspitali University HospitalRecruitingFrailty Syndrome | Elective Surgery | Frailty in Adult SurgeryIceland
-
University of NottinghamRecruitingFrailty | Diet | Systemic Inflammatory Response | Dietary Fiber | Frailty at Older Adults | Pre-FrailtyUnited Kingdom
-
Ji Yan Biomedical Co., Ltd.YC Biotech Co., Ltd.Not yet recruiting
-
Maximilian KönigNot yet recruiting
-
Instituto Tecnologico y de Estudios Superiores...Not yet recruiting
-
Xijing HospitalEnrolling by invitationFrailty SyndromeChina
Clinical Trials on Implementation as usual
-
Alicia BungerNot yet recruitingSubstance Use Disorder | Opioid Use Disorder | Implementation | Child Maltreatment | Peer Recovery Supporters
-
University of AarhusAalborg UniversityCompleted
-
University of PennsylvaniaCompletedImplementation ScienceUnited States
-
VA Office of Research and DevelopmentVA Boston Healthcare SystemCompleted
-
Michigan State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingMaternal Mortality Disparities | Maternal Morbidity DisparitiesUnited States
-
VU University of AmsterdamLondon School of Hygiene and Tropical Medicine; Northumbria University; Region... and other collaboratorsCompletedTailored Implementation: Online ItFits-toolkit | Implementation as UsualNetherlands, Albania, Australia, Denmark, France, Germany, Italy, Kosovo, Spain
-
Washington University School of MedicineUniversity of Missouri-Columbia; National Institute of Diabetes and Digestive... and other collaboratorsRecruitingObesity | Weight Management | Obesity Prevention | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
George Washington UniversityKing's College London; Duke University; World Health Organization; Transcultural...CompletedDepression | Psychological Distress | Posttraumatic Stress DisorderNepal
-
George Washington UniversityKing's College London; Duke University; World Health Organization; Transcultural...Completed
-
Yale UniversityNational Institute of Allergy and Infectious Diseases (NIAID)CompletedTuberculosis | Tuberculosis, PulmonaryUganda